Liangchao Ni
Overview
Explore the profile of Liangchao Ni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
459
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wu Y, Cao F, Lei H, Zhang S, Mei H, Ni L, et al.
Abdom Radiol (NY)
. 2024 May;
49(9):3096-3106.
PMID: 38733392
Background: To develop and compare machine learning models based on triphasic contrast-enhanced CT (CECT) for distinguishing between benign and malignant renal tumors. Materials And Methods: In total, 427 patients were...
2.
Chen W, Wang W, Zhao Z, Wen Z, Li Y, Ge Z, et al.
Front Oncol
. 2024 May;
14:1391844.
PMID: 38720802
Background: Renal cell carcinoma (RCC) stands as the most prevalent form of urogenital cancer. However, there is currently no universally accepted method for predicting the prognosis of RCC. MiRNA holds...
3.
Chen P, Quan J, Jin L, Lin C, Xu W, Xu J, et al.
Exp Ther Med
. 2024 Mar;
27(4):155.
PMID: 38476890
[This corrects the article DOI: 10.3892/etm.2018.5881.].
4.
Lai Y, Quan J, Lin C, Li H, Hu J, Chen P, et al.
Exp Ther Med
. 2024 Feb;
27(4):134.
PMID: 38414790
[This corrects the article DOI: 10.3892/etm.2018.6151.].
5.
Lai Y, Zhao L, Hu J, Quan J, Chen P, Xu J, et al.
Mol Med Rep
. 2024 Feb;
29(4).
PMID: 38362959
Following the publication of the above article and a corrigendum in 2018 that corrected details of the correspondence information for authors, errors made in Fig. 5 and the funding details...
6.
Wen Z, Li Y, Zhao Z, Li R, Li X, Lu C, et al.
Cancer Cell Int
. 2024 Jan;
24(1):18.
PMID: 38191389
Background: Although non-invasive radiological techniques are widely applied in kidney renal clear cell carcinoma (KIRC) diagnosis, more than 50% of KIRCs are detected incidentally during the diagnostic procedures to identify...
7.
Li X, Wen Z, Li R, Lu C, Chen W, Chen X, et al.
Clin Genitourin Cancer
. 2023 Aug;
22(1):23-32.
PMID: 37574436
Background: Renal cell carcinoma (RCC) carries significant morbidity and mortality globally with an increasing incidence per year predominantly represented by clear-cell renal cell carcinoma (ccRCC) which accounts for 70-80% of...
8.
Li R, Chen W, Lu C, Li X, Chen X, Huang G, et al.
Front Oncol
. 2023 Feb;
12:1076303.
PMID: 36727070
Background: Renal cell carcinoma (RCC) is one out of the most universal malignant tumors globally, and its incidence is increasing annually. MicroRNA (miRNA) in serum could be considered as a...
9.
Li H, Huang G, Lai Y, Ni L, Lai Y
Oncol Res Treat
. 2022 Mar;
45(6):344-352.
PMID: 35231919
Objective: Urothelial carcinoma (UCa) is one of the most common malignancies of the genitourinary system, and its early diagnosis is vital to improve the survival of UCa patients. Therefore, novel...
10.
Huang G, Li H, Wang J, Peng X, Liu K, Zhao L, et al.
Pathol Res Pract
. 2020 Aug;
216(11):153152.
PMID: 32823234
Background: Renal cell carcinoma (RCC) accounts for 3 % of cancer patients. Early detection influences the therapeutic strategy and significantly improves patients' survival rates. Stable existing circulating miRNAs could be...